Shanghai Daily news

Shares in Shanghai fell slightly yesterday, led by stocks in the pharmaceutical sector as the central government is reportedly planning to pass some bitter medicines to crack down on sky-high prices.
The Shanghai Composite Index, which tracks both yuan-denominated A shares and hard-currency B shares, dipped 0.16 percent to 1,072.14. The A-share Index eased 0.15 percent to 1,125.27, and the B-share Index trimmed 0.64 percent to close at 67.83.
"Medicine shares used to be one of those that performed relatively strong. So its downside today (Wednesday) brought gloom to the market," said Chen Qun, an analyst with West China Securities Co Ltd.
"But the deeper impact of the news will depend on what types of medicines that the central government is likely to put a curb on," she added.
The Ministry of Health will take steps to curb the soaring prices of medicines, said Xinhua news agency.
The ministry plans to waive the right of hospitals to raise medicine prices by up to 15 percent, and therefore curb the practice of many doctors selling unnecessary and expensive drugs to patients, Han was quoted as saying.
The move will help improve the country's health sector, but it is also likely to hit the sales of drug makers.
Tianjin Tasly Pharmaceutical Co Ltd plummeted 8.87 percent to end at 12.33 yuan (US$1.48). Shanghai Modern Pharmaceutical Co Ltd dived 7.21 percent to  11.58 yuan.